- Home
- FANG vs COR Comparison
FANG vs COR Comparison
Compare FANG & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FANG
- COR
- Stock Information
- Founded
- FANG 2007
- COR 2001
- Country
- FANG United States
- COR United States
- Employees
- FANG N/A
- COR N/A
- Industry
- FANG Oil & Gas Production
- COR Other Pharmaceuticals
- Sector
- FANG Energy
- COR Health Care
- Exchange
- FANG Nasdaq
- COR Nasdaq
- Market Cap
- FANG 52.6B
- COR 44.4B
- IPO Year
- FANG 2012
- COR N/A
- Fundamental
- Price
- FANG $180.18
- COR $242.06
- Analyst Decision
- FANG Buy
- COR Buy
- Analyst Count
- FANG 21
- COR 11
- Target Price
- FANG $214.48
- COR $268.09
- AVG Volume (30 Days)
- FANG 2.3M
- COR 1.2M
- Earning Date
- FANG 02-24-2025
- COR 02-05-2025
- Dividend Yield
- FANG 4.60%
- COR 0.91%
- EPS Growth
- FANG N/A
- COR N/A
- EPS
- FANG 17.29
- COR 7.53
- Revenue
- FANG $9,157,000,000.00
- COR $293,958,599,000.00
- Revenue This Year
- FANG $36.80
- COR $9.98
- Revenue Next Year
- FANG $35.11
- COR $6.47
- P/E Ratio
- FANG $10.42
- COR $32.14
- Revenue Growth
- FANG 18.25
- COR 12.12
- 52 Week Low
- FANG $147.93
- COR $214.77
- 52 Week High
- FANG $214.50
- COR $253.27
- Technical
- Relative Strength Index (RSI)
- FANG 67.74
- COR 64.12
- Support Level
- FANG $177.65
- COR $233.61
- Resistance Level
- FANG $180.25
- COR $241.14
- Average True Range (ATR)
- FANG 3.76
- COR 3.94
- MACD
- FANG 2.18
- COR 1.86
- Stochastic Oscillator
- FANG 96.98
- COR 91.11
About FANG Diamondback Energy Inc.
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2023, the company reported net proven reserves of 2.2 billion barrels of oil equivalent. Net production averaged about 448,000 barrels per day in 2023, at a ratio of 59% oil, 21% natural gas liquids, and 20% natural gas.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.